Ryan D. Maynard

2009

In 2009, Ryan D. Maynard earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$168,000
Option Awards$703,170
Salary$300,000
Other$540
Total$1,171,710

Maynard received $703.2K in option awards, accounting for 60% of the total pay in 2009.

Maynard also received $168K in non-equity incentive plan, $300K in salary and $540 in other compensation.

Rankings

In 2009, Ryan D. Maynard's compensation ranked 3,919th out of 9,885 executives tracked by ExecPay. In other words, Maynard earned more than 60.4% of executives.

ClassificationRankingPercentile
All
3,919
out of 9,885
60th
Division
Manufacturing
1,392
out of 3,690
62nd
Major group
Chemicals And Allied Products
264
out of 866
70th
Industry group
Drugs
154
out of 638
76th
Industry
Pharmaceutical Preparations
121
out of 446
73rd
Source: SEC filing on April 12, 2012.

Maynard's colleagues

We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2009.

2009

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2009

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2009

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2009

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

In-depth

You may also like